Clinical Trial Update: Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rapamycin for longevity in aging, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: AgelessRx | Conditions: Aging | Phase 2 | Status: COMPLETED